Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis
Chiara Bellocchi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Shervin Assassi(University of Houston), Maureen D. Mayes(The University of Texas Health Science Center), Keith M. Sullivan(Duke Medical Center), Jonathan Goldin(UCLA Health), Monique Hinchcliff(Yale University), Daniel E. Furst(University of California, Los Angeles), Richard A. Nash(Colorado Blood Cancer Institute), Leslie J. Crofford(Vanderbilt University Medical Center), Marka A. Lyons(The University of Texas Health Science Center), Binwu Ying(Sichuan University), Peter A. McSweeney(Mesoblast (United States)), Lynette Keyes‐Elstein(Rho (United States)), Beverly Welch(National Institute of Allergy and Infectious Diseases), Ashley Pinckney(National Institute of Allergy and Infectious Diseases), Ellen Goldmuntz(National Institute of Allergy and Infectious Diseases), John Varga(Michigan Medicine)
Cited by 15
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k